Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 23 04:00PM ET
9.12
Dollar change
-0.33
Percentage change
-3.49
%
IndexRUT P/E- EPS (ttm)-0.92 Insider Own70.61% Shs Outstand37.23M Perf Week-0.87%
Market Cap501.60M Forward P/E- EPS next Y- Insider Trans2.81% Shs Float16.17M Perf Month4.83%
Income-39.47M PEG- EPS next Q- Inst Own8.09% Short Float16.29% Perf Quarter37.97%
Sales-0.01M P/S- EPS this Y- Inst Trans-15.35% Short Ratio8.95 Perf Half Y20.00%
Book/sh0.95 P/B9.62 EPS next Y- ROA-51.43% Short Interest2.63M Perf Year253.49%
Cash/sh0.92 P/C9.95 EPS next 5Y- ROE-135.34% 52W Range2.36 - 13.62 Perf YTD-25.49%
Dividend Est.- P/FCF- EPS past 5Y0.07% ROI-65.23% 52W High-33.04% Beta1.68
Dividend TTM- Quick Ratio9.50 Sales past 5Y-12.66% Gross Margin-4734.38% 52W Low286.44% ATR (14)0.67
Dividend Ex-Date- Current Ratio9.50 EPS Y/Y TTM54.49% Oper. Margin442066.67% RSI (14)51.89 Volatility5.99% 7.51%
Employees61 Debt/Eq0.18 Sales Y/Y TTM-100.58% Profit Margin438600.00% Recom3.00 Target Price5.00
Option/ShortYes / Yes LT Debt/Eq0.16 EPS Q/Q60.37% Payout- Rel Volume0.46 Prev Close9.45
Sales Surprise- EPS Surprise- Sales Q/Q- EarningsNov 13 BMO Avg Volume294.34K Price9.12
SMA203.34% SMA50-4.23% SMA20029.88% Trades Volume135,399 Change-3.49%
Date Action Analyst Rating Change Price Target Change
Jul-27-21Initiated Stephens Overweight $28
Mar-11-21Initiated Maxim Group Buy $40
Jan-26-21Reiterated H.C. Wainwright Buy $16 → $40
May-12-20Upgrade H.C. Wainwright Neutral → Buy $6 → $16
Feb-14-20Downgrade H.C. Wainwright Buy → Neutral $26 → $6
Feb-25-19Initiated H.C. Wainwright Buy $27
Feb-14-24 08:00AM
Jan-31-24 08:00AM
Jan-02-24 08:00AM
Dec-20-23 08:00AM
Nov-21-23 08:00AM
04:05PM Loading…
Nov-15-23 04:05PM
Nov-14-23 12:52PM
02:15AM
Nov-13-23 11:13AM
08:00AM
Nov-10-23 04:56PM
Oct-30-23 04:05PM
Oct-24-23 08:00AM
Oct-02-23 08:00AM
Sep-29-23 08:00AM
08:00AM Loading…
Sep-27-23 08:00AM
Sep-07-23 04:05PM
Aug-24-23 04:05PM
Aug-17-23 09:31AM
Aug-11-23 06:28AM
Aug-10-23 04:05PM
Jul-30-23 09:35AM
Jul-27-23 04:05PM
May-22-23 09:30AM
May-18-23 07:00AM
May-16-23 12:01PM
May-12-23 07:43AM
May-11-23 04:05PM
May-10-23 09:29AM
May-03-23 08:00AM
08:00AM Loading…
May-01-23 08:00AM
Apr-27-23 04:05PM
Apr-20-23 06:04AM
Apr-05-23 07:46PM
Mar-30-23 04:05PM
Mar-10-23 08:30AM
Mar-02-23 04:05PM
Feb-02-23 08:00AM
Dec-10-22 07:24AM
Nov-10-22 04:05PM
Oct-27-22 04:05PM
Oct-14-22 06:17AM
Oct-06-22 08:00AM
Oct-01-22 08:50AM
Sep-26-22 10:00AM
08:00AM
Sep-21-22 10:03AM
Sep-20-22 04:26PM
Aug-10-22 05:25PM
04:05PM
Aug-04-22 08:00AM
Jul-27-22 04:05PM
Jun-16-22 04:15PM
Jun-09-22 04:43PM
Jun-03-22 08:00AM
May-19-22 08:00AM
May-13-22 01:44PM
May-11-22 06:05PM
04:05PM
May-04-22 08:00AM
Apr-28-22 08:00AM
Apr-26-22 08:00AM
Apr-14-22 04:05PM
Mar-31-22 05:25PM
04:05PM
Mar-21-22 04:05PM
Mar-17-22 06:57AM
Feb-15-22 08:00AM
Feb-08-22 12:37PM
08:45AM
Feb-01-22 04:05PM
Jan-11-22 07:00AM
Dec-28-21 02:38AM
Dec-17-21 09:20AM
Nov-25-21 10:00AM
Nov-18-21 04:05PM
Nov-15-21 04:05PM
Nov-04-21 04:05PM
Nov-02-21 04:05PM
Oct-05-21 08:00AM
Sep-02-21 04:05PM
12:43PM
Aug-19-21 04:05PM
Aug-09-21 04:05PM
Jul-26-21 04:05PM
Jul-06-21 01:34AM
Jul-01-21 05:45PM
08:00AM
Jun-30-21 10:56AM
10:20AM
Jun-11-21 06:17AM
Jun-09-21 09:05AM
08:00AM
May-24-21 08:00AM
May-13-21 09:16AM
May-11-21 07:17AM
May-10-21 04:05PM
02:30PM
Apr-26-21 04:05PM
Apr-22-21 08:00AM
Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DUGGAN ROBERT WDirectorDec 12Buy9.1517,999164,69136,984,179Dec 14 07:37 PM
DUGGAN ROBERT WDirectorDec 11Buy9.3690,118843,50436,966,180Dec 13 06:03 PM
DUGGAN ROBERT WDirectorDec 08Buy9.54116,6561,112,89836,876,062Dec 12 07:28 PM
DUGGAN ROBERT WDirectorDec 07Buy9.1974,852687,89036,759,406Dec 11 08:13 PM
DUGGAN ROBERT WDirectorDec 06Option Exercise5.959,93359,10136,601,741Dec 08 07:38 PM
DUGGAN ROBERT WDirectorDec 06Buy9.0682,813750,28636,684,554Dec 08 07:38 PM
DUGGAN ROBERT WDirectorDec 05Buy9.3466,021616,636351,565Dec 07 08:34 PM
DUGGAN ROBERT WDirectorDec 04Option Exercise10.6640,347430,09936,591,808Dec 06 07:54 PM
DUGGAN ROBERT WDirectorDec 04Buy10.3827,000280,260285,544Dec 06 07:54 PM
DUGGAN ROBERT WDirectorDec 01Buy9.0745,600413,592258,544Dec 05 08:31 PM
DUGGAN ROBERT WDirectorNov 30Buy9.06152,9441,385,673212,944Dec 04 07:37 PM
DUGGAN ROBERT WDirectorNov 29Option Exercise5.951,6679,91936,392,861Dec 01 07:36 PM
DUGGAN ROBERT WDirectorNov 29Buy9.44158,6001,497,18436,551,461Dec 01 07:36 PM
DUGGAN ROBERT WDirectorNov 29Buy9.2160,000552,60060,000Dec 01 07:36 PM
DUGGAN ROBERT WDirectorNov 28Buy8.98124,3971,117,08536,391,194Nov 30 07:25 PM
DUGGAN ROBERT WDirectorNov 17Buy6.1020,241123,47036,266,797Nov 20 08:56 PM
Danahy Kevin PatrickChief Executive OfficerNov 16Buy6.525,39335,15635,887Nov 17 09:11 AM
Levinson Mitchell E.Chief Strategy OfficerNov 15Buy5.9113,53980,0589,135Nov 17 09:10 AM
Levinson Mitchell E.Chief Strategy OfficerNov 15Buy5.874,26125,03373,027Nov 17 09:10 AM
Zanganeh MahkamDirectorNov 13Option Exercise2.1476,075162,800604,911Nov 15 05:37 PM
DUGGAN ROBERT WDirectorNov 07Option Exercise5.9513,26578,92736,246,556Nov 09 06:32 PM
DUGGAN ROBERT WDirectorAug 25Option Exercise5.951,6679,91936,233,291Aug 28 08:08 PM
DUGGAN ROBERT WDirectorJul 25Option Exercise5.951,6679,91936,231,624Jul 27 09:09 AM
DUGGAN ROBERT WDirectorJul 07Option Exercise2.2367,133150,01236,229,957Jul 07 06:26 PM
DUGGAN ROBERT WDirectorJul 05Option Exercise2.1465,000139,10036,162,824Jul 07 06:26 PM
DUGGAN ROBERT WDirectorMay 09Buy6.5110,022,93765,249,32030,414,661May 10 05:41 PM